VAERS Explorer
Back to explore

Report #2830322

Received Mar 10, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
20 yrs
State
—
Recovered
Recovered
Vaccinated
Nov 26, 2024
Onset
Nov 26, 2024
Days to onset
0
Hospital days
—

Vaccines (4)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (UNKNOWN))UNKNOWN MANUFACTURER36024MF016AOT
HPV9HPV (GARDASIL 9)MERCK & CO. INC.11957404OT
MENMENINGOCOCCAL (NO BRAND NAME)UNKNOWN MANUFACTURER2U8370AAOT
VARCELVARICELLA (VARIVAX)MERCK & CO. INC.1Y005919OT

Symptoms (1)

Urticaria

Symptom narrative

He developed hives on his right thigh and lower le; Initial information received on 28-Feb-2025 regarding an unsolicited valid non-serious Courtesy case received from a consumer/non-health care professional. This case involves a 20 years adult male patient who had developed hives on his right thigh and lower leg after receiving Varivax (Varicella zoster vaccine live (Oka/Merck)), Gardasil 9 (HPV vaccine VLP rL1 9v (yeast)), Novavax COVID-19 Vaccine(COVID-19 vaccine prot. subunit (NVX CoV 2373)) and Meningococcal A-C-Y-W135 (T Conj) Vaccine [Menquadfi]. The patient's past medical history included Headache. The patient's past medical treatment(s), vaccination(s) ,concomitant medications and family history were not provided. On 26-Nov-2024, the patient received a dose 2 of suspect Meningococcal A-C-Y-W135 (T Conj) Vaccine (Solution for injection) lot U8370AA via intramuscular route in unknown administration site, a dose 3 of suspect Novavax COVID-19 Vaccine not produced by Sanofi Pasteur Injection lot 6024MF016A via intramuscular route in unknown administration site for COVID-19 Vaccination, a dose 1 of suspect Varivax not produced by Sanofi Pasteur Injection lot Y005919 via intramuscular route in unknown administration site, a dose 1 of suspect Gardasil 9 not produced by Sanofi Pasteur Injection lot 1957404 via intramuscular route in unknown administration site and On 07-Jan-2025 he also received a dose 1 of vaccine 1957404 via intramuscular route in unknown administration site for all Prophylactic vaccination (Immunization) (strength, expiry date was unknown for all the suspects). On 26-NOV-2024 the patient developed hives on his right thigh and lower leg (urticaria) (latency : same day) following the administration of Meningococcal A-C-Y-W135 (T Conj) Vaccine, Novavax COVID-19 Vaccine, Gardasil 9 and Varivax. Action taken was not applicable. The patient was treated with Cetirizine hydrochloride (Zyrtec) for Urticaria. At time of reporting, the outcome was Recovered / Resolved on 26-Nov-2024 for the event he developed hives on his right thigh and lower le.

Medical history

Medical History/Concurrent Conditions: Headache